Rapid Time to Clinic

Lowest Cost at Every Stage

LAB2LAUNCH

keyboard_arrow_left Swipe for More
Learn more keyboard_arrow_up

From Lab…

  • Rapid production of candidate molecules for lead selection
  • Protein function composition improvement
  • Protein yield and stability optimization

To Launch

  • Production process development and scale-up
  • Bulk drug substance for clinical trials in under six months
  • Facility capacity of 300 kg per year

LAB2LAUNCH

Regulatory Intelligence

Early Stage Biotechs Rely on iBio’s Regulatory Guidance

  • Initial risk assessment in pre-clinical environment
  • E-publishing of Pre-IND and IND packages
  • iBio and preferred partner CBR deliver support throughout the entire IND process
  • Ex-FDA experts provide insider knowledge
  • Eliminate the need for additional quality assurance professionals

LAB2LAUNCH

Start Over